Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)

Summary

This study investigated the onset of symptom relief following initiation of treatment with mometasone furoate (MK-0887/SCH 032088) 200 mcg administered once daily compared with placebo for 14 days.

Timeline

Start

1994-03-30

Primary completion

1994-06-27

Completion

1994-07-07

Outcome

Met primary endpoint

registry analysis (other test); Mometasone Furoate Nasal Spray vs Placebo Nasal Spray; p <0.01; Log Rank NCT03861559 ↗

Drugs

Indications